OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Nephrology is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
A UMOD variant with intermediate effects	723
Mentorship in the lives of scholars	474
Engineered CAR macrophages target kidney inflammation	399
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	382
The GLP-1 receptor agonist revolution comes to nephrology	339
Making advance care planning easier for adults with kidney disease and their clinicians	339
Role of the gut microbiota in the pathogenesis of IgA nephropathy	338
Disaster preparedness for patients with kidney disease	307
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	256
Uropathogen and host responses in pyelonephritis	247
Designing acute kidney injury clinical trials	223
Kidney health within the broader non-communicable disease agenda	198
Vaccination in patients with kidney failure: lessons from COVID-19	196
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	175
Treatment of chronic kidney disease in older populations	172
A single-cell atlas of DKD treatment responses	171
Daprodustat for anaemia in CKD	159
Roles of sensory receptors in non-sensory organs: the kidney and beyond	157
Beyond state borders: transforming dialysis care for undocumented immigrants	154
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	151
Genetic determinants of urine and plasma metabolite levels	149
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	149
Consideration of sex differences is necessary to achieve health equity	142
Complosome — the intracellular complement system	139
Phosphate sensing via PTC glycolysis	133

Interferon blockade in lupus: effects on antiviral immunity	132
Mutational signatures of ccRCC vary between geographical regions	131
Bringing Pride to nephrology	130
Reducing preventable acute kidney injury in a hospital setting	128
Clonal haematopoiesis and AKI	126
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	126
The effects of sex hormone therapy on kidney function	122
Informing clinical decision making during a pandemic — a call for better preparedness	120
The roles of hyaluronan in kidney development, physiology and disease	118
Menopause and chronic kidney disease	117
Aquaporin water channels: roles beyond renal water handling	116
Increasing diversity and inclusion in nephrology clinical trials	108
Benefits of actin cytoskeleton stabilization	107
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	105
From mapping kidney function to mechanism and prediction	103
Identification of erythropoietin-producing cells	102
NUAK1 promotes kidney fibrosis	100
Design of a renal-sparing antifungal	94
Tertiary lymphoid organs contribute to kidney allograft rejection	93
Heat and health inequity: acting on determinants of health to promote heat justice	92
Treatment of SLE with anti-CD19 CAR-T cells	84
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	83
Pathological mechanisms of kidney disease in ageing	83
Neutrophils and NETs in kidney disease	82
Long-term health outcomes associated with hydration status	78
Salt substitution: opportunities and challenges for nephrology	77
From fat to filter: the effect of adipose tissue-derived signals on kidney function	75
RNA-binding proteins and their role in kidney disease	73
The evolving landscape of immune-mediated glomerular diseases	72
The role of complement in kidney disease	72
Reaping the rewards of mechanistic discovery in glomerular disease	71
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	69
An integrated approach towards a public health perspective on chronic kidney disease	64
MSC therapy for diabetic kidney disease and nephrotic syndrome	64
Network medicine: an approach to complex kidney disease phenotypes	64
A pathway of osmotic stress-induced necroptosis	63
Reducing stress-induced CHOP is renoprotective	63